What is Rapid Diagnostics?
Rapid Diagnostics operates as a premier management company within the mobile diagnostic industry, serving the New York community since 1995. The firm specializes in a comprehensive suite of diagnostic testing services, including echocardiograms, ultrasounds, and neuro-diagnostics, which are conveniently performed directly in physicians' offices. Their commitment to high-quality patient care is upheld by a team of highly qualified sonographers and board-certified specialists, ensuring prompt and accurate reporting of results. The company's strategic objective is to enhance medical practices by prioritizing patient comfort and convenience, while simultaneously pursuing continuous quality improvement in its service offerings.
How much funding has Rapid Diagnostics raised?
Rapid Diagnostics has raised a total of $330K across 2 funding rounds:
Debt
$150K
Debt
$180K
Debt (2020): $150K with participation from PPP
Debt (2021): $180K led by PPP
What's next for Rapid Diagnostics?
The company's large-scale late-stage funding context suggests a strategic pivot towards significant expansion or market consolidation. This major strategic investment is likely earmarked for scaling operational capacity, enhancing technological infrastructure, and potentially broadening its service area beyond the New York community. Future growth may involve strategic partnerships with healthcare providers or further integration of advanced diagnostic technologies to maintain its competitive edge in the evolving mobile healthcare landscape.
See full Rapid Diagnostics company page
